M. Alhenc‐Gelas

发表

Three novel mutations of antithrombin inducing high-molecular-mass compounds.

D. Vidaud, J. Emmerich, M. Aiach, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

Diagnostic score for heparin‐induced thrombocytopenia after cardiopulmonary bypass

P. Boutouyrie, I. Gautier, A. L. Louët, 2004, Journal of thrombosis and haemostasis : JTH.

Poor performance of albumin or protein-adjusted plasma calcium to diagnose dyscalcemia in hospitalized patients: A confirmatory study in a general internal medicine department.

E. Letavernier, G. Grateau, C. Bachmeyer, 2021, La Revue de medecine interne.

Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin.

P. Morange, Y. Gruel, E. de Maistre, 2006, Blood.

Comparative Analysis of a French Prospective Series of 144 Patients with Heparin-Induced Thrombocytopenia (FRIGTIH) and the Literature

B. Giraudeau, V. Gouilleux-Gruart, E. de Raucourt, 2020, Thrombosis and Haemostasis.

Mutations des protéines de la coagulation et thromboses

J. Emmerich, M. Aiach, V. Picard, 2006 .

Five novel mutations located in exons III and IX of the protein C gene in patients presenting with defective protein C anticoagulant activity.

M. Aiach, P. Gaussem, S. Gandrille, 1993, Blood.

Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic risk.

L. Guize, V. Nicaud, J. Emmerich, 1999, Arteriosclerosis, Thrombosis and Vascular Biology.

Two novel mutations responsible for hereditary type I protein C deficiency: Characterization by denaturing gradient gel electrophoresis

M. Vidaud, M. Goossens, J. Fiessinger, 1992, Human mutation.

Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the behalf of INSERM.

J. Griffin, B. Jude, J. Abgrall, 1995, Blood.

Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.

P. Ducimetiere, L. Guize, S. Consoli, 2006, The American journal of cardiology.

Antithrombin Rybnik: a new point mutation (nt 683 G>T) associated with type I antithrombin deficiency in a patient with venous thromboembolism and recurrent superficial venous thrombosis.

M. Szymańska, A. Undas, M. Alhenc‐Gelas, 2013, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Novel Splice Site Mutation in the PROS1 Gene in a Polish Patient with Venous Thromboembolism: c.602-2delA, Splice Acceptor Site of Exon 7

A. Undas, D. P. Potaczek, E. Wypasek, 2020, Medicina.

Monitoring unfractionated heparin with APTT: a French collaborative study comparing sensitivity to heparin of 15 APTT reagents.

E. Peynaud-Debayle, M. Alhenc‐Gelas, I. Martin-Toutain, 2012, Thrombosis research.

Protein C and protein S deficiencies.

J. Emmerich, M. Aiach, P. Gaussem, 1997, Seminars in hematology.

PROS1 mutations associated with protein S deficiency in Polish patients with residual vein obstruction on rivaroxaban therapy.

A. Undas, D. P. Potaczek, E. Wypasek, 2014, Thrombosis research.

Heparin‐induced thrombocytopenia: Construction of a pretest diagnostic score derived from the analysis of a prospective multinational database, with internal validation

P. Morange, Y. Gruel, P. Nguyên, 2021, Journal of thrombosis and haemostasis : JTH.

Presentation, management and outcome of heparin-induced thrombocytopenia after valvular heart surgery.

B. Iung, P. Steg, A. Vahanian, 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Protein C infusion in a patient with inherited protein C deficiency caused by two missense mutations: Arg 178 to Gln and Arg‐1 to His

J. Emmerich, J. Fiessinger, M. Aiach, 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Genetic characterization of antithrombin, protein C, and protein S deficiencies in Polish patients.

J. Corral, J. Musial, A. Blecharczyk, 2017, Polish archives of internal medicine.

Protein S deficiency and Heerlen polymorphism in a Polish patient with acute myocardial infarction and previous venous thromboembolism.

A. Undas, D. P. Potaczek, J. Płonka, 2013, Thrombosis research.

Hormone Replacement Therapy and Circulating ICAM-1 in Postmenopausal Women

E. Oger, P. Scarabin, M. Alhenc‐Gelas, 1999, Thrombosis and Haemostasis.

A missense mutation G109R in the PROC gene associated with type I protein C deficiency in a young Polish man with acute myocardial infarction.

J. Trębacz, A. Undas, D. P. Potaczek, 2013, International journal of cardiology.

The effects of transdermal and oral estrogen/progesterone regimens on free and total protein S in postmenopausal women.

E. Oger, P. Scarabin, M. Alhenc‐Gelas, 2001, Thrombosis and haemostasis.

Two new antithrombin variants support a role for K114 and R13 in heparin binding

S. Susen, M. Aiach, V. Picard, 2003, Journal of thrombosis and haemostasis : JTH.

Met 358 to Arg mutation of alpha 1-antitrypsin associated with protein C deficiency in a patient with mild bleeding tendency.

D. Vidaud, J. Emmerich, J. Fiessinger, 1992, The Journal of clinical investigation.

FIRST DE NOVO MUTATIONS IN THE PROTEIN C GENE OF TWO PATIENTS WITH TYPE I DEFICIENCY : A MISSENSE MUTATION AND A SPLICE SITE DELETION

B. Jude, J. Emmerich, M. Aiach, 1994 .

First de novo mutations in the protein C gene of two patients with type I deficiency: a missense mutation and a splice site deletion.

B. Jude, J. Emmerich, M. Aiach, 1994, Blood.

Unexplained thrombosis and factor V Leiden mutation

J. Emmerich, J. Fiessinger, M. Aiach, 1994, The Lancet.

The FXIII Val 34 Leu Mutation and the Risk of Venous Thrombosis

J. Reny, J. Emmerich, M. Aiach, 2000, Thrombosis and Haemostasis.

Recurrent ischemic cerebrovascular events in a patient with type I antithrombin deficiency caused by 9788 G>A splice site mutation: a case report.

M. Szymańska, A. Undas, M. Alhenc‐Gelas, 2013, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

The Factor V Gene A4070G Mutation and the Risk of Venous Thrombosis

V. Nicaud, J. Emmerich, J. Fiessinger, 1999, Thrombosis and Haemostasis.

An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy

J. Fiessinger, M. Aiach, P. Priollet, 1987, British journal of haematology.

Molecular bases of antithrombin deficiency: twenty‐two novel mutations in the antithrombin gene

C. Vergnes, C. Frère, C. Biron-Andréani, 2006, Human mutation.

Fetal intracerebral hemorrhage in familial thrombophilia.

C. Fallet-Bianco, M. Fontenay, G. Grangé, 2009, Pediatric neurology.

Antithrombin Katowice: exon 1 deletion in the SERPINC1 gene associated with type I antithrombin deficiency.

J. Corral, M. Cieśla, A. Undas, 2015, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Antithrombin Krakow II (c.624+1 G > T): a novel mutation leading to type 1 antithrombin deficiency.

J. Musial, T. Iwaniec, A. Undas, 2012, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Molecular basis for hereditary antithrombin III quantitative deficiencies: a stop codon in exon IIIa and a frameshift in exon VI

D. Vidaud, J. Emmerich, J. Fiessinger, 1991, British journal of haematology.

Deep venous thrombosis associated with factor V Leiden, G20210A mutation, and protein S deficiency.

J. Monsuez, A. Boissonnas, E. Serve, 2003, The American journal of medicine.

Clinical Features in 36 Patients Homozygous for the ARG 506 → GLN Factor V Mutation

B. Jude, J. Emmerich, J. Fiessinger, 1997, Thrombosis and Haemostasis.

The A20210 allele of the prothrombin gene is not frequently associated with the factor V Arg 506 to Gln mutation in thrombophilic families.

T. Frebourg, J. Emmerich, J. Fiessinger, 1997, Blood.

Antiphospholipid antibodies and atherosclerosis.

P. Bruneval, J. Fiessinger, M. Aiach, 1992, The American journal of medicine.

Mutations in promoter region of thrombomodulin and venous thromboembolic disease.

M. Alhenc-Gelas, J. Emmerich, J. Fiessinger, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.

M. Aiach, R. Agher, P. Scarabin, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Rat high-molecular-weight kininogen: purification, production of antibodies and demonstration of lack of immunoreactive kininogen in a strain of brown Norway rats.

J. Ménard, P. Corvol, F. Alhenc-Gelas, 1985, Biochimica et biophysica acta.

Anti-cardiolipin antibodies are associated with anti-endothelial cell antibodies but not with anti-beta 2 glycoprotein I antibodies in HIV infection.

M. Kazatchkine, L. Weiss, P. Giral, 1995, Clinical immunology and immunopathology.

Venous thromboembolism associated with protein S deficiency due to $$\hbox {Arg}451^{*}$$Arg451∗ mutation in PROS1 gene: a case report and a literature review

A. Undas, E. Wypasek, M. Alhenc‐Gelas, 2017, Journal of Genetics.

Thrombomodulin Promoter Mutations, Venous Thrombosis, and Varicose Veins

M. Alhenc-Gelas, J. Emmerich, M. Aiach, 2001, Arteriosclerosis, thrombosis, and vascular biology.

[Changes in levels of blood coagulation inhibitors in cirrhosis. Prospective study in 33 patients].

G. Chatellier, M. Aiach, I. Dumontier, 1992, Gastroentérologie Clinique et Biologique.

Detection and characterisation of large SERPINC1 deletions in type I inherited antithrombin deficiency

B. Tardy, J. Emmerich, Jian-Min Chen, 2009, Human Genetics.

Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol

V. Remones, M. Aiach, P. Gaussem, 2011, Thrombosis and Haemostasis.

Prothrombotic Mutations, Hormone Therapy, and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration

E. Oger, J. Emmerich, H. Lévesque, 2005, Circulation.

Conformational Asn187Asp/Lys antithrombin variants and thrombosis

B. Jude, A. Bauters, M. Aiach, 2004, Thrombosis and Haemostasis.

Factors V leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis.

V. Nicaud, M. Alhenc-Gelas, J. Emmerich, 2001, The American journal of medicine.

Compound Heterozygosity in a Family with Protein C Deficiency Illustrating the Complexity of the Underlying Molecular Mechanism

B. Jude, A. Millaire, M. Aiach, 1993, Thrombosis and Haemostasis.

Influence of three potential genetic risk factors for thrombosis in 43 families carrying the factor V Arg 506 to Gln mutation

D. Trégouët, J. Emmerich, J. Fiessinger, 1999, British journal of haematology.

Late Onset of Clinical Symptoms and Recurrent Ecchymotic Skin Lesions in a 12-Year-Old Girl With a Severe Double Heterozygous Protein C Deficiency

A. Ferster, F. Corazza, A. Demulder, 2004, Journal of pediatric hematology/oncology.

Molecular Basis of Antithrombin Type I Deficiency: The First Large In-frame Deletion and Two Novel Mutations in Exon 6

J. Emmerich, J. Fiessinger, M. Aiach, 1994, Thrombosis and Haemostasis.

A phenylalanine 402 to leucine mutation is responsible for a stable inactive conformation of antithrombin.

J. Emmerich, J. Fiessinger, M. Aiach, 1994, Thrombosis research.

Arterial and venous thrombosis and prothrombotic fibrin clot phenotype in a Polish family with type 1 antithrombin deficiency (antithrombin Krakow)

M. Alhenc-Gelas, J. Musial, T. Iwaniec, 2011, Thrombosis and Haemostasis.

Antithrombin Phe229Leu: a new homozygous variant leading to spontaneous antithrombin polymerization in vivo associated with severe childhood thrombosis.

B. Villoutreix, M. Dautzenberg, G. Orliaguet, 2003, Blood.

Molecular bases of antithrombin deficiency in French families: identification of seven novel mutations in the antithrombin gene

A. Bura, C. Biron, J. Emmerich, 2000, British journal of haematology.

Molecular basis for antithrombin III type I deficiency: three novel mutations located in exon IV.

D. Vidaud, J. Emmerich, M. Aiach, 1991, Blood.

Activated protein C resistance caused by factor V Arg 506-->Gln mutation has no role in thrombotic manifestations of Behçet's disease.

J. Piette, B. Wechsler, M. Aiach, 1995, Annals of the rheumatic diseases.

Evaluation of APC Resistance in the Plasma of Patients with Q506 Mutation of Factor V (Factor V Leiden) and Treated by Oral Anticoagulants

M. Aiach, P. Sié, Y. Cadroy, 1995, Thrombosis and Haemostasis.

Characterization of two novel splice site mutations in human factor VII gene causing severe plasma factor VII deficiency and bleeding diathesis

K. Borensztajn, M. Alhenc-Gelas, A. Fischer, 2002, British journal of haematology.

Protective effect of a thrombin receptor (protease-activated receptor 1) gene polymorphism toward venous thromboembolism.

V. Nicaud, M. Alhenc-Gelas, J. Emmerich, 2000, Arteriosclerosis, thrombosis, and vascular biology.

The −33T → C Polymorphism in Intron 7 of the TFPI Gene Influences the Risk of Venous Thromboembolism, Independently of the Factor V Leiden and Prothrombin Mutations

B. Grandchamp, M. Alhenc-Gelas, J. Emmerich, 2002, Thrombosis and Haemostasis.

A meta-analysis of genome-wide association studies identifies ORM1 as a novel gene controlling thrombin generation potential.

F. Cambien, L. Letenneur, D. Trégouët, 2014, Blood.

The Ser 460 to Pro substitution of the protein S alpha (PROS1) gene is a frequent mutation associated with free protein S (type IIa) deficiency.

M. Aiach, D. Borgel, S. Gandrille, 1995, Blood.

[Renal biopsy practice: results of a French study and recommendations].

P. Houillier, M. Alhenc-Gelas, P. Deteix, 2012, Nephrologie & therapeutique.

Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.

P. Scarabin, L. Guize, E. Oger, 2001, Thrombosis research.

Thirty-three Novel Mutations in the Protein C Gene

M. Aiach, S. Gandrille, M. Aubry, 2000, Thrombosis and Haemostasis.

Response to DDAVP stimulation in thirteen patients with Buerger's disease.

J. Fiessinger, M. Aiach, P. Gaussem, 1997, Thrombosis research.

The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case–control study

P. Fontana, J. Emmerich, M. Aiach, 2004, Journal of thrombosis and haemostasis : JTH.

Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives

M. Alhenc-Gelas, M. Aiach, P. Scarabin, 2004, Journal of thrombosis and haemostasis : JTH.

Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen

M. Alhenc-Gelas, P. Scarabin, V. Olié, 2010, Menopause.

Increased Thrombin Generation Is Associated With Acute Ischemic Stroke but Not With Coronary Heart Disease in the Elderly: The Three-City Cohort Study

J. Dartigues, Y. Béjot, P. Ducimetiere, 2011, Arteriosclerosis, thrombosis, and vascular biology.

[A new hereditary cause of portal vein thrombosis: the abnormal resistance to activated protein C by the Arg 506-->Gln mutation of the gene of factor V].

F. Bloch, D. Levoir, J. Petite, 1995, Gastroenterologie clinique et biologique.

Portal Vein Thrombosis and Factor V Arg 506 to GIn Mutation

J. Emmerich, J. Fiessinger, M. Aiach, 1995, Thrombosis and Haemostasis.

Association of postmenopausal hormone replacement therapy with carotid atherosclerosis and soluble thrombomodulin: the vascular aging (EVA) study. Etude du Vieillissement Artériel.

P. Touboul, M. Zureik, F. V. van Oort, 2002, Thrombosis research.

Venous Thromboembolic Disease and the Prothrombin, Methylene Tetrahydrofolate Reductase and Factor V Genes

V. Nicaud, J. Emmerich, J. Fiessinger, 1999, Thrombosis and Haemostasis.

PROS1 genotype phenotype relationships in a large cohort of adults with suspicion of inherited quantitative protein S deficiency

A. Rauch, P. Suchon, M. Horellou, 2015, Thrombosis and Haemostasis.

A New Assay Based on Thrombin Generation Inhibition to Detect Both Protein C and Protein S Deficiencies in Plasma

S. Béguin, M. Alhenc-Gelas, M. Aiach, 1994, Thrombosis and Haemostasis.

Differential Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Sensitivity to Activated Protein C Among Postmenopausal Women: A Randomized Trial

Dominique Mottier, Emmanuel Oger, Véronique Kerlan, 2003, Arteriosclerosis, thrombosis, and vascular biology.

Adjusted Versus Fixed Doses of the Low-Molecular-Weight Heparin Fragmin in the Treatment of Deep Vein Thrombosis

M. Alhenc-Gelas, J. Fiessinger, M. Aiach, 1994, Thrombosis and Haemostasis.

Protein S inherited qualitative deficiency: novel mutations and phenotypic influence

M. Alhenc-Gelas, J. Emmerich, M. Canonico, 2010, Journal of thrombosis and haemostasis : JTH.

Purpura Fulminans in a Patient Homozygous for a Mutation in the Protein C Gene - Prenatal Diagnosis in a Subsequent Pregnancy

M. Alessi, I. Juhan-vague, B. Roquelaure, 1996, Thrombosis and Haemostasis.

A rapid screening method for the factor V Arg506→Gln mutation

M. Aiach, S. Gandrille, M. Alhenc‐Gelas, 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Protein C Concentrates in a Neonate with a Cerebral Venous Thrombosis due to Heterozygous Type 1 Protein C Deficiency

M. Lavocat, I. Rayet, B. Tardy‐Poncet, 2001, Thrombosis and Haemostasis.

Novel missense mutation C106R in the PROC gene associated with type I protein C deficiency in a young Polish man with high-risk pulmonary embolism.

A. Undas, D. P. Potaczek, E. Wypasek, 2014, Polskie Archiwum Medycyny Wewnetrznej.

Demonstration of an Association between Chlamydia pneumoniae Infection and Venous Thromboembolic Disease

V. Nicaud, O. Lozinguez, M. Alhenc-Gelas, 2000, Thrombosis and Haemostasis.

Activated partial thromboplastin time sensitivity to lupus anticoagulant in a patient with transient arthritis and lupus anticoagulant-hypoprothrombinemia syndrome

J. Pouchot, L. Darnige, L. Mauge, 2015, Annals of Hematology.

Gross deletions/duplications in PROS1 are relatively common in point mutation-negative hereditary protein S deficiency

P. Reitsma, C. Spek, D. Borgel, 2009, Human Genetics.

Plasma 17beta estradiol is inversely correlated with circulating vascular cell adhesion molecule.

L. Guize, E. Oger, P. Scarabin, 2000, Thrombosis and Haemostasis.

Resistance to activated protein C: role in venous and arterial thrombosis.

M. Alhenc-Gelas, J. Emmerich, J. Fiessinger, 1996, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Plasma 17β Estradiol Is Inversely Correlated with Circulating Vascular Cell Adhesion Molecule

L. Guize, E. Oger, P. Scarabin, 2000, Thrombosis and Haemostasis.

Venous Thrombosis in Older People: Prevalence of the Factor V Gene Mutation Q506

M. Alhenc-Gelas, P. Gaussem, V. Siguret, 1998, Journal of the American Geriatrics Society.

Thrombotic risk according to SERPINC1 genotype in a large cohort of subjects with antithrombin inherited deficiency

J. Hugon-Rodin, M. Horellou, V. Picard, 2017, Thrombosis and Haemostasis.

Hypercoagulable states in primary upper-extremity deep vein thrombosis.

E. Héron, O. Lozinguez, M. Alhenc-Gelas, 2000, Archives of internal medicine.

Mechanism of protein C deficiency in a patient with arginine 358 alpha 1-antitrypsin (Pittsburgh mutation): role in the maintenance of hemostatic balance.

J. Emmerich, J. Fiessinger, M. Aiach, 1995, Journal of Laboratory and Clinical Medicine.

Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral Therapy

D. Costagliola, M. Alhenc-Gelas, C. Didier, 2016, Journal of acquired immune deficiency syndromes.

[Genetics of venous thromboembolism].

M. Aiach, M. Alhenc‐Gelas, 2003, Archives des maladies du coeur et des vaisseaux.

Influence of natural SERPINC1 mutations on ex vivo thrombin generation

M. Alhenc-Gelas, V. Picard, M. Canonico, 2010, Journal of thrombosis and haemostasis : JTH.

Sex hormone-binding globulin and thrombin generation in women using hormonal contraception

H. Hemker, M. Alhenc-Gelas, J. Hugon-Rodin, 2017, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Homozygous protein C deficiency with a double variant His 202 to Tyr and Ala 346 to Thr.

N. Akar, S. Kemahlı, M. Aiach, 1998, Blood Coagulation and Fibrinolysis.

Genotype–Phenotype Relationships in a Large French Cohort of Subjects with Inherited Protein C Deficiency

S. Gandrille, L. Mauge, M. Alhenc‐Gelas, 2020, Thrombosis and Haemostasis.

Molecular basis for protein S hereditary deficiency: genetic defects observed in 118 patients with type I and type IIa deficiencies. The French Network on Molecular Abnormalities Responsible for Protein C and Protein S Deficiencies.

M. Aiach, D. Borgel, S. Gandrille, 1996, The Journal of laboratory and clinical medicine.

Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens

M. Alhenc-Gelas, P. Scarabin, H. Hemker, 2011, Menopause.

[Stability of coagulation parameters: review of available data].

Laetitia Mauge, Martine Alhenc-Gelas, L. Mauge, 2014, Annales de biologie clinique.

Multifactorial hypercoagulable state associated with a thrombotic phenotype in phosphomannomutase-2 congenital disorder of glycosylation (PMM2-CDG): Case report and brief review of the literature.

L. Drouet, V. Siguret, P. Charles, 2019, Thrombosis research.

Heparin-induced thrombocytopenia: Successful biological and clinical management with lepirudin despite severe renal impairment

J. Duranteau, C. Ract, M. Dreyfus, 2011, Thrombosis and Haemostasis.

Influence of Six Mutations of the Protein C Gene on the Gla Domain Conformation and Calcium Affinity

J. Emmerich, M. Aiach, P. Gaussem, 1994, Thrombosis and Haemostasis.

Antithrombin Cambridge II (A384S): prevalence in patients of the Paris Thrombosis Study (PATHROS).

J. Emmerich, M. Aiach, V. Picard, 2007, Blood.

Genetic variation at the estrogen receptor α locus in relation to venous thromboembolism risk among postmenopausal women

M. Aubry, P. Scarabin, C. Straczek, 2005, Journal of thrombosis and haemostasis : JTH.

Specificity of an Assay Based on a Factor V-depleted Plasma in Patients Carrying the Arg 506 GIn Mutation

M. Aiach, I. Juhan-vague, M. Aillaud, 1996, Thrombosis and Haemostasis.

Familial thrombophilia is an oligogenetic disease: involvement of the prothrombin G20210A, PROC and PROS gene mutations

A. Kitzis, M. Alhenc-Gelas, M. Aiach, 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Homozygous G20210A Transition in the Prothrombin Gene Associated with Severe Venous Thrombotic Disease: Two Cases in a French Family

B. Jude, C. Preudhomme, C. Zawadzki, 1998, Thrombosis and Haemostasis.

Heparin-induced Thrombocytopenia Diagnosis: A Retrospective Study Comparing Heparin-induced Platelet Activation Test to 14 C-serotonin Release Assay

N. Gendron, B. Tardy, Marie-Charlotte Bourrienne, 2021, TH Open.